Recherche
Résultats 21-30 de 38
-
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
The New England journal of medicine, 2018, 379, 934-947Article dans une revue scientifique -
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis
The Lancet. Haematology, 2018, 5, E359-E367Article dans une revue scientifique -
Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
The Lancet. Haematology, 2018, 5, E403-E410Article dans une revue scientifique -
An open-label, phase Ib study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma.
Blood, 2018Article dans une revue scientifique -
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial
Journal of Oncology Practice, 02-2017, 35 (5), 536-543Article dans une revue scientifique -
Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy
Journal of clinical oncology, 2017, 35, 1905-+Article dans une revue scientifique -
Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment
Bulletin du cancer, 2017, 104, 221-231Article dans une revue scientifique -
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Blood, 2017, 129, 2616-2623Article dans une revue scientifique -
Allogeneic hematopoietic cell transplantation for Hodgkin''s disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bulletin du cancer, 2017, 104, S112-S120Article dans une revue scientifique -
Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Bulletin du cancer, 2017, 104, S106-S111Article dans une revue scientifique